Stem cell services provider WideCells Group PLC (LON:WDC) has launched the first stage of Wideacademy, the firm’s 100%-owned education and training division.
The group said its newly launched platform provides content for both the public and medical professionals to raise the profile of stem cell technologies and support the development of the industry.
It also combines free-to-access educational areas with paid for premium digital tools and resources for doctors/medical professionals.
Joao Andrade, WideCells’s CEO, said: “Wideacademy, together with our stem cell insurance product, CellPlan, are the first products of their kind, and it is our ability to recognise industry and find solutions to overcome them, which I believe sets us apart and puts us on the path for significant growth.”
WATCH: WideCells Group strengthens board; launches Wideacademy
WideCells also announced that it has appointed David Henriques as a new non-executive director. In his new role Henriques, who has asset management and corporate finance experience, will succeed Zakaria Aziz.
The company added that with a strengthened board and three active divisions, its primary focus is on building a global profile and increasing client reach and driving sales of its stem cell services.
Andrade said: ”Our sights are now on growth and commercial roll-out. In support of this, we have identified significant development opportunities in the Asia-pacific territories, where the stem cell industry is gaining increasing profile.”